Continuous Glucose Monitoring Following Hospital Discharge

NAActive, not recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2025

Conditions

Type 2 Diabetes

Interventions

DEVICE

DexCom G6

Wearable continuous glucose monitor

Trial Locations (1)

The Ohio State University Medical Center - Outpatient Care East, Columbus

All Listed Sponsors

collaborator

DexCom, Inc.

INDUSTRY

lead

Kathleen Dungan

OTHER